Background. Increased numbers of mast cells are found in various solid tumors. To investigate the role of mast cells in the vicinity of gastric cancer cells, we used special staining and an immunohistochemical technique. Methods. Specimens were surgically obtained from 102 patients with gastric cancer. Mast cells around the tumor edge of gastric cancer nests were counted by staining with 0.05% toluidine blue solution. Blood vessels in these areas were also counted, by immunohistochemical staining of endothelial cells for factor VIII. Results. The average number of mast cells and blood vessels in gastric cancer specimens was significantly higher than that in normal gastric tissue. Specimens from patients with advanced disease with metastases to lymph nodes had more mast cells than specimens from patients with early-stage disease. Mast cells in specimens from patients with metastatic lymph nodes were significantly increased in comparison with numbers in specimens from those without nodal metastases. Mast cell numbers in the specimens of patients with lymphatic or blood vessel invasion were significantly higher than numbers in specimens from patients without such invasion. Mast cells were localized near the new vessels around gastric cancer cells. Mast cell numbers increased as the number of blood vessels increased (correlation coefficient, 0.783). Postoperative survival curves revealed that patients with increased numbers of mast cells had a poor prognosis. Conclusions. All these results suggest that mast cell accumulation at the tumor site may lead to increased rates of tumor vascularization and, consequently, increased rates of tumor growth and metastasis.
Introduction
A variety of studies have demonstrated that an increased number of mast cells is an early and persistent finding in various naturally occurring solid tumors. Baroni [1] reported increased mast cell numbers in several tumors, including neurofibromas, lipomas, and hemangiomas, a result later confirmed by Glowacki and Mulliken [2] and by Ho [3] . Increased numbers of mast cells have also been reported in human adrenocortical tumors [4] and in a variety of skin tumors [5] . In experimental animals, mast cell infiltration and degranulation were observed to be concurrent with the development of epidermoid carcinomas in carcinogen-treated hamsters [6] and were seen at the periphery of tumors implanted onto the chorioallantoic membranes of chick embryos [7] . However, the roles of mast cells around cancer cells are obscure.
New blood vessel formation in the vicinity of cancer cells, or tumor angiogenesis, is a fundamental component of tumorigenesis, tumor growth, and metastasis. Weidner et al. [8] reported a significant correlation between the density of microvessels in histologic sections of invasive breast carcinoma stained for factor VIII and the occurrence of metastases. In a variety of tumors, such as gastric cancer and breast cancer, the vessel density is reported to be a prognostic indicator [9, 10] . To date, more than a dozen purified molecules have been shown to be angiogenic, such as acidic and basic fibroblast growth factor (aFGF, bFGF), vascular endothelial growth factor (VEGF), epidermal growth factor (EGF), and platelet-derived endothelial cell growth factor (PD-ECGF).
To identify the role of mast cells around gastric cancer cells, we investigated the relationship between numbers of mast cells and microvessels by special staining for mast cells and immunohistochemical staining, using an anti-human factor VIII polyclonal antibody. Our preliminary clinicopathological and immunohistochemical characterization suggests that mast cell infiltration around gastric cancer cells correlates with tumor angiogenesis and metastasis.
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Subjects and methods
Patients
One hundred and two patients with adenocarcinoma of the stomach were included in this study, a group which consisted of 75 men and 27 women whose mean age was 60.3 years (range, 35-87 years). Specimens were obtained from these patients with gastric cancer who underwent distal gastrectomy or total gastrectomy with regional lymph node dissection at the Department of Surgery, at Osaka Teishin Hospital, between 1995 and 1997. The patients did not receive any anticancer therapy before surgery. Normal gastric tissues were also obtained, as well as the gastric tumors.
Mast cell staining
The specimens were fixed with 10% neutral buffered formalin, embedded in paraffin, cut in 4-µm-thick sections, and stained with 0.05% toluidine blue solution, pH 4.1 (Muto Pure Chemicals, Tokyo, Japan), for 30 min to detect mast cells [11] .
Blood vessel staining
All blood vessels around the gastric cancer cells of 49 patients were highlighted by staining endothelial cells for factor VIII, by the streptavidin-biotin method [12] . The sections were dewaxed in xylene and taken through ethanol. After the blocking of endogeneous peroxidase activity, the sections were incubated with 3.0% normal goat serum for 30 min to prevent nonspecific binding. They were then washed with phosphate-buffered saline (PBS), and incubated with anti-human factor VIII polyclonal antibody (Dako, Tokyo, Japan) at room temperature for 20 min. They were well washed with PBS and incubated with biotinylated anti rabbit IgG diluted in PBS containing 1.0% normal goat serum for 30 min. After being washed with PBS, they were incubated with streptavidin-biotin peroxidase reagent for 30 min. Peroxidase staining was performed for 4 min, using a solution of 40 mg 3,3Ј-diaminobenzidine tetrahydrochloride in 200 ml 0.05 M pH 7.6 Tris-HCl buffer containing 40 µl of 30% hydrogen peroxide. The slides were immersed in 0.05% toluidine blue solution for 30 min to perform double staining of mast cells and blood vessels.
Histological findings and determination of mast cell and blood vessel numbers
Mast cells and blood vessels around the tumor edge of gastric cancer nests were counted using a light microscope (number per 100ϫ field). The average number of mast cells and blood vessels in three fields selected at random was calculated. The tumors were classified pathologically according to the 12th Japanese edition of the General rules for gastric cancer study [13] .
Prognosis
The prognosis of the patients was examined on September 30, 1998. Survival curves for patients were calculated using the Kaplan-Meier method and analyzed by the general Wilcoxon test.
Statistics
Data values were statistically analyzed by Student's t-test. Probability values less than 0.05 were considered significant.
Results
Mast cell and factor VIII expression
The granules in mast cell cytoplasm were stained purple by toluidine blue, and the blood vessels were stained brown by anti-factor VIII polyclonal antibody. In normal gastric tissue, mast cells existed diffusely from the submucosa to the muscle layer; the average number was 27 Ϯ 1 per field (ϫ100) by light microscope (Fig. 1) . The average mast cell number (70 Ϯ 6) in the tumor tissue of 102 patients with gastric cancer was significantly higher than that in normal gastric tissue (Fig. 2) . The average number of blood vessels from the submucosa to the muscle layer in normal gastric tissue was 22 Ϯ 2. The average number of blood vessels in the tumor tissue of 49 patients with gastric cancer (54 Ϯ 5) was significantly higher than that in normal gastric tissue (Table 1) . Table 2 shows the correlation among clinicopathological factors, mast cell numbers, and blood vessel numbers in the patients with gastric cancer. We analyzed the data according to depth of gastric cancer invasion. The abbreviations used for histology are: tub1, well differentiated tubular adenocarcinoma; tub2, moderately differentiated tubular adenocarcinoma; por1, Fig. 1 . Mast cells were stained purple and blood vessels were stained brown by double staining with toluidine blue and antifactor VIII polyclonal antibody. In normal gastric tissue, mast cells and blood vessels existed diffusely from the submucosa to the muscle layer; the average mast cell number was 27 Ϯ 1 and average blood vessel number was 22 Ϯ 2 per high-power (100ϫ) field by light microscope. ϫ100 t3, 23 lymph-node-positive patients had a significantly higher number of mast cells than 20 lymph-node-negative patients (Fig. 3) . Figure 4 shows the correlation between mast cell number and blood vessel number around gastric cancer cells. When the blood vessel numbers were plotted against the mast cell numbers, a significant correlation was found between the numbers of blood vessels and the numbers of mast cells around gastric cancer cells (r ϭ 0.783; P Ͻ 0.0001). Table 2 footnote for definitions of t2 and t3) 
Correlation between clinicopathological factors and mast cell numbers
Prognosis
The patients specimens were divided into two groups: those with a low number of mast cells (less than 70 mast cells per visual field) (n ϭ 73) and those with an increased number of mast cells (more than 70 mast cells per visual field) (n ϭ 29). The overall survival rate is shown in Fig. 5 . The 3-year survival rate was 93.1% in the group with a low number histologic sections of gastric cancer. The number of mast cells correlated significantly with the depth of invasion, lymph node metastasis, lymphatic or vessel invasion, and the histologic stage. The number of mast cells also correlated with the number of blood vessels around gastric cancer cells; the correlation coefficient was 0.783. In the histologic sections, mast cells were localized near the new microvessels; we also found many degranulated mast cells (Fig. 7) .
Many tumor-associated mast cells have been found to undergo degranulation and release of granular components such as heparin and histamine [6] . Mast cell granule products, including heparin and histamine, have been shown to potentiate endothelial cell migration [14] and proliferation [15] and to induce adhesion molecule expression on endothelial cells, potentially leading to (n ϭ 102) . The 3-year survival rate was 93.1% in the group with a low number of mast cells, and 47.4% in the group with an increased number of mast cells. There was a significant difference between the two groups (P Ͻ 0.0001) Fig. 6 . Postoperative survival curves in t2/ t3 patients (n ϭ 43). The 3-year survival rate of the patients with t2/t3 was 82.6% in the group with a low number of mast cells, and 41.1% in the group with an increased number of mast cells. A significant difference was seen between these groups (P Ͻ 0.05) of mast cells, and 47.4% in the group with the increased number of mast cells. There was a significant difference between the two groups (P Ͻ 0.0001). The 3-year survival rate of the patients with t2 or t3 was 82.6% in the group with a low number of mast cells, and 41.1% in the group with an increased number of mast cells (Fig. 6) . A significant difference was seen between these groups (P Ͻ 0.05).
Discussion
Mast cells and blood vessels were clearly two-color stained by double staining of toluidine blue and factor VIII, so they were easily recognized from other cells. We confirmed an increased number of mast cells in factor [24] . The tumor-derived autocrine motility factor [25] may have a key role in stimulating tumor autocrine motility, as well as the motility of mast cells around gastric cancer cells. Further studies of the correlation between autocrine motility factor and mast cells may be warranted.
increased tumor angiogenesis and metastasis [16] . Tumors injected into mast-cell deficient mice [17] or into mice treated with inhibitors of mast cell degranulation [18, 19] show decreased tumor vascularity, tumor growth, and metastasis, indicating that mast cell granule products enhance tumor growth and metastasis, leading to the suggestion that anti-mast cell agents may be useful in cancer chemotherapy. Endothelial cell migration and proliferation will accelerate tumor angiogenesis around gastric cancer cells. The postoperative survival curve in our series revealed that patients with an increased number of mast cells had a poorer prognosis than patients with a low number of mast cells. All these results suggest that mast cell accumulation at the tumor site may lead to increased rates of tumor vascularization and consequently, increased rates of tumor growth and metastasis.
The accumulation of mast cells in tumors could be due to the active migration of mast cells or mast cell precursors to the tumor site in response to tumorderived chemoattractants. It is now known that both mucosal and connective tissue-type mast cells are motile and respond to the migration activity of a variety of agents including the tripeptide glycylhistidyllysine [20] , interleukin-3 [21] , stem cell factor [22] , and laminin fragment containing the IKVAV domain [23] . The role of these factors in tumor-directed mast cell migration has not been thoroughly investigated and none have been directly implicated in this process. We previously reported the purification of tumor-derived mast cell motility factor from a murine bladder carcinoma cell line that stimulated the migration of cultured marrowderived mast cells in vitro [24] . Further characterization revealed that the mast cell motility factor had the physical and biological properties of the autocrine motility 
